Sleep Apnea
FDA Accepts NDA for AD109, Potential First Oral Drug to Treat Neuromuscular Cause of Sleep Apnea
4 sources · 10d ago
Sleep Science
Landmark Study Finds Optimal Sleep Window (6.4-7.8 Hours) for Lowest Biological Aging Signals
2 sources · 12d ago
Sleep Apnea
FDA Approves First-Ever Drug Treatment for Obstructive Sleep Apnea
2 sources · 17d ago
More in Sleep
Heart HealthExplainer
Landmark 10-Year Study Finds Irregular Bedtimes Double Risk of Heart Attack and Stroke
Chronobiologists & Sleep Researchers 40%Cardiologists & Clinical Practitioners 40%Public Health Advocates 20%
6 sources · 18d ago
Sleep ApneaExplainer
The Evidence Pack: How a Once-Nightly Pill Targets the Neuromuscular Root Cause of Sleep Apnea
Sleep Medicine Physicians 40%Pharmaceutical Developers 35%Patient Advocates 25%
3 sources · 27d ago
Factlen ExplainerSleep Science
How Temperature and Light Optimize Deep Sleep and Brain Health
Sleep Scientists & Neurologists 40%Circadian Biologists 35%Clinical Practitioners 25%
5 sources · 41d ago






